We found that Tα1 protects mice from anti–CTLA-4–induced colitis by engaging the IDO1 tolerogenic pathway in the gut, while sustaining the antitumor activity via DCs and lymphocyte infiltration at the tumor site. This evidence concerns the gene CTLA4 and neoplasm.